Comparing Integrative Midwife-led vs. Fragmented Inpatient Postpartum Care: Impact on Satisfaction and Transition to Motherhood

NCT07077941 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 784

Last updated 2025-07-22

No results posted yet for this study

Summary

The goal of this clinical trial is to compare two different forms of postnatal care to find out which is most beneficial for mothers and their children after birth and with which they are most satisfied. One is a nurse-led, seperate model of care and the other is a midwife-led, integrative model of care. Participants are healthy women between the ages of 18 and 50. They gave birth between 36+0 and 42+0 weeks of pregnancy and had a child. The type of birth is not an inclusion or exclusion criteria. Our hypotheses are: i) that maternal satisfaction with care in a midwife-led, integrative care model is higher than in separate maternal and infant care; ii) that a positive postpartum experience leads to earlier and increased maternity competence; iii) that a higher breastfeeding rate at the time of the survey in the fourth month can be achieved through integrative care. Participants will be randomly assigned, after birth of their child, to either the group cared for by a nurse or the group cared for by a midwife.

Conditions

  • Maternal Health Services
  • Infant, Newborn
  • Postnatal Care
  • Breast Feeding
  • Maternal-Child Relations
  • Postpartum Depression (PPD)
  • Mental Health
  • Lactation
  • Breast Feeding, Exclusive
  • Patient Satisfaction and Experience With Integrative Therapies
  • Neonatal Jaundice
  • Maternal Behavior
  • Body Weight Decreased
  • Breast Feeding of Healthy Full Term Infants
  • Lactation Mastitis
  • Lactation Disorder - Postpartum Condition or Complication
  • Lactation Disorder With Baby Delivered
  • Lactation; Insufficient, Partial

Interventions

OTHER

Integrative care

Joint care of mother and child by just one healthcare professional

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Tanja A. Stamm, PhD · Institute for Outcomes Research Center for Medical Data Science Medical University of Vienna

  • Alex Farr, PhD · Medical University of Vienna, Dept. of Obstetrics and Gynecology, Division of Feto-Maternal Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07077941 on ClinicalTrials.gov